
Kevin joins from Pharmaventures where he was head of transactions. He brings with him over 30 years of experience in pharma, biotechnology and business advisory. He has an extensive track record of successful deal-making including transactions with Merck, UCB and Sanofi. Kevin has also previously worked at Roche, Quintiles, Sanofi (Hoechst) and Inpharmatica.